EAGAN, Minn., June 27, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence…
Anavex and Partex agreed to enter into a strategic partnership to leverage Partex’s proprietary AI (Artificial Intelligence) technology for Anavex’s…
BOSTON, June 26, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on developing novel…
Patent EP 3 332 028 B1 granted by the European Patent Office covers the identification and use of genomic variants…
Interventional study to evaluate long term outcomes of Volta’s AI solution-supported ablation in recurrent-AF patients who failed previous ablationInternational, multi-center…
Video Represents Latest in the Company’s “Director’s Forum” Series – Observations from the Company’s Independent DirectorsMIAMI, June 21, 2023 (GLOBE…
With millions of Americans experiencing mental health symptoms, 23andMe+ members now have exclusive access to four mental health reports to…
Teladoc Health and Humana Veteran Will Lead the Company’s Technology, Product Development, and Data Analytics Functions Julia Zhang, Chief Technology…
EAGAN, Minn., June 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence…
The study represents a significant breakthrough in understanding the potential for reversing and measuring epigenetic changes associated with coronary heart…